Osteopathic Manipulative Medicine to Reduce Developmental Delays
Completed · Not applicable
Conditions studied: Extreme Prematurity, Neurodevelopmental Abnormality
In brief
This randomized clinical trial seeks to determine if osteopathic manipulative medicine (OMM) increases the likelihood of improved neurodevelopmental outcomes as estimated by the Test of Infant Motor Performance (TIMP).
Key facts
- Study ID
- NCT04652063
- Run by
- University of Rochester
- People needed
- 150
- Starts
- 2021-01-05
- Expected to finish
- 2023-07-30
- Last updated by the study team
- 2023-08-14
Who can join
Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 23 0/7- 33 6/7 weeks' gestational age (GA) at birth, ≥28 0/7 weeks' GA at time of consent
- stable enough to tolerate gentle manipulation
You may not qualify if…
- > 33 6/7 weeks' GA at birth
- known congenital and genetic abnormalities affecting neurodevelopment
- known conditions requiring surgical intervention
- severe intracranial hemorrhage or other severe neurologic complications
- parents unable to read and understand English
Where it is running
- Golisano Children's Hospital — Rochester, New York, United States
- University of Rochester — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.